Pages that link to "Q37098291"

The following pages link to Utility of KRAS mutation detection using circulating cell-free DNA from patients with colorectal cancer (Q37098291):

Displaying 18 items.

• Asymmetrical barcode adapter-assisted recovery of duplicate reads and error correction strategy to detect rare mutations in circulating tumor DNA. (Q33623264) (← links)
• The role of cell-free DNA in predicting colorectal cancer prognosis (Q38637642) (← links)
• Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer (Q40437996) (← links)
• Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits. (Q41620161) (← links)
• Oncological Assessment of Stent Placement for Obstructive Colorectal Cancer from Circulating Cell-Free DNA and Circulating Tumor DNA Dynamics (Q47299547) (← links)
• Significance of Liquid Biopsy for Monitoring and Therapy Decision of Colorectal Cancer (Q48503747) (← links)
• Circulating tumor DNA is effective for detection of KRAS mutation in colorectal cancer: a meta-analysis (Q50198030) (← links)
• Next Generation Sequencing: From Research Area to Clinical Practice (Q59336423) (← links)
• Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer (Q61455455) (← links)
• Cell-free DNA testing: future applications in gastroenterology and hepatology (Q64115892) (← links)
• The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta-analysis (Q64118154) (← links)
• Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease (Q87891522) (← links)
• An enzymatic on/off switch-mediated assay for KRAS hotspot point mutation detection of circulating tumor DNA (Q90620153) (← links)
• Early change in circulating tumor DNA as a potential predictor of response to chemotherapy in patients with metastatic colorectal cancer (Q91405316) (← links)
• The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer (Q91869042) (← links)
• Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment (Q92431759) (← links)
• Analysis of colorectal cancer-related mutations by liquid biopsy: Utility of circulating cell-free DNA and circulating tumor cells (Q92983460) (← links)
• Circulating Tumor DNA Analysis: Clinical Implications for Colorectal Cancer Patients. A Systematic Review (Q93200678) (← links)